The ETS Homologous Factor (EHF) Represents a Useful Immunohistochemical Marker for Predicting Prostate Cancer Metastasis

The ETS Homologous Factor (EHF) Represents a Useful Immunohistochemical Marker for Predicting Prostate Cancer Metastasis

The main aim of this study was to investigate the risk of prostate cancer metastasis formation associated with the expression of ETS homologous factor (EHF) in a cohort of bioptic samples. To this end, the expression of EHF was evaluated in a cohort of 152 prostate biopsies including primary prostat...

Full description

Bibliographic Details
Main Authors: Manuel Scimeca, Manuela Montanaro, Rita Bonfiglio, Lucia Anemona, Enrico Finazzi Agrò, Anastasios D. Asimakopoulos, Roberto Bei, Vittorio Manzari, Nicoletta Urbano, Erica Giacobbi, Francesca Servadei, Elena Bonanno, Orazio Schillaci, Alessandro Mauriello
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Diagnostics
Subjects:
prostate cancer
ETS homologous factor
metastasis
histological marker
Online Access:https://www.mdpi.com/2075-4418/12/4/800

Internet

https://www.mdpi.com/2075-4418/12/4/800

Similar Items